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Fig. S6
. T 1 -weighted MRI images of subcutaneous UM mice before and after administration of Cys-ProCA32.CXCR4, blocking reagent + Cys-ProCA32.CXCR4, and Lys-ProCA32 (n = 3 for each group). Tumors are identified by red arrows. Three groups of mice exhibited tumor signal intensity increases at 3 h after injection of contrast agents. Mice that received injection of Cys-ProCA32.CXCR4 presented further tumor signal enhancement at 24 h after injection, and signal intensity then washed out at 48 h. CXCR4 blocking reagent pre-treated mice and Lys-ProCA32 administration showed signal wash out at 24 h and a further decrease at 48 h. ICP-OES analysis of Gd 3+ content in different mouse organs. Mice (n = 3) organs, including muscle, heart, kidney, liver, brain, lung, and spleen, were collected five days after injection of 0.035 mmol/kg of either Lys-ProCA32.CXCR4 or CysProCA32.CXCR4. Organs with the most Gd 3+ distribution were the liver and spleen. Low amounts of Gd 3+ were found in brain (0.07 % Injection Dosage/g tissue), muscle, and heart tissues. Moderate concentration of Gd 3+ were found in both kidney and lung tissues.
Fig. S8
. H&E staining analysis of mice tissues collected 7 and 14 days after injection of CysProCA32.CXCR4. Mice (n=3) organs, including brain, kidney, heart, spleen, muscle, lung, and liver were collected 7 and 14 days after injection of 0.035 mmol/kg Cys-ProCA32.CXCR4. No observable tissue damage occurred in the mouse organs. Table S1 . Relaxivities of investigated contrast agents in 10 mM Hepes at 37°C. Table S2 . Clinical pathology profile of mouse serum. Mouse serum samples collected 2 days after injection of saline (control, n = 3) or 0.025 mmol/kg of Lys-ProCA32.CXCR4/CysProCA32.CXCR4 (n = 3) were used for pathology profiling. Data are expressed as mean  SD.
